CN100475777C - 酰胺型甲酰胺衍生物 - Google Patents
酰胺型甲酰胺衍生物 Download PDFInfo
- Publication number
- CN100475777C CN100475777C CNB2004800280312A CN200480028031A CN100475777C CN 100475777 C CN100475777 C CN 100475777C CN B2004800280312 A CNB2004800280312 A CN B2004800280312A CN 200480028031 A CN200480028031 A CN 200480028031A CN 100475777 C CN100475777 C CN 100475777C
- Authority
- CN
- China
- Prior art keywords
- compound
- gram
- reaction
- obtains
- milliliters
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
- C07C237/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrrole Compounds (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Abstract
Description
Claims (6)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP334595/2003 | 2003-09-26 | ||
JP2003334595 | 2003-09-26 | ||
PCT/JP2004/013892 WO2005030706A1 (ja) | 2003-09-26 | 2004-09-24 | アミド型カルボキサミド誘導体 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1860097A CN1860097A (zh) | 2006-11-08 |
CN100475777C true CN100475777C (zh) | 2009-04-08 |
Family
ID=34386034
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2004800280312A Expired - Fee Related CN100475777C (zh) | 2003-09-26 | 2004-09-24 | 酰胺型甲酰胺衍生物 |
Country Status (17)
Country | Link |
---|---|
US (1) | US7375119B2 (zh) |
EP (1) | EP1666455A4 (zh) |
JP (1) | JP4571075B2 (zh) |
KR (1) | KR100740820B1 (zh) |
CN (1) | CN100475777C (zh) |
AR (1) | AR045816A1 (zh) |
AU (1) | AU2004276128B2 (zh) |
BR (1) | BRPI0414460A (zh) |
CA (1) | CA2538072C (zh) |
IL (1) | IL174188A0 (zh) |
MX (1) | MXPA06003382A (zh) |
NO (1) | NO20061832L (zh) |
NZ (1) | NZ546160A (zh) |
RU (1) | RU2307829C2 (zh) |
TW (1) | TW200512181A (zh) |
WO (1) | WO2005030706A1 (zh) |
ZA (1) | ZA200602131B (zh) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7875627B2 (en) * | 2004-12-07 | 2011-01-25 | Abbott Laboratories | Thienopyridyl compounds that inhibit vanilloid receptor subtype 1 (VR1) and uses thereof |
TW200734304A (en) * | 2005-11-08 | 2007-09-16 | Astellas Pharma Inc | Benzene derivative or salt thereof |
JP5290186B2 (ja) | 2006-11-15 | 2013-09-18 | ヴァイロケム ファーマ インコーポレイテッド | フラビウイルス感染症の治療または予防用のチオフェン類似体 |
UA94639C2 (ru) | 2007-02-02 | 2011-05-25 | Пфайзер Продактс Інк. | Трициклические соединения и их применение как модуляторов глюкокортикоидного рецептора |
EP2070924A1 (de) | 2007-12-10 | 2009-06-17 | Bayer Schering Pharma Aktiengesellschaft | Neue 2-Hetarylthiazol-4-carbonsäureamid-Derivative, deren Herstellung und Verwendung als Arzneimittel |
EP2070916A1 (de) | 2007-12-10 | 2009-06-17 | Bayer Schering Pharma Aktiengesellschaft | 2-Aryl-thiazol-4-carbonsäureamid-Derivate, deren Herstellung und Verwendung als Arzneimittel |
EP2070925A1 (de) | 2007-12-10 | 2009-06-17 | Bayer Schering Pharma Aktiengesellschaft | Neue 2-substituierte Tiazol-4-carbonsäureamid-Derivative deren Herstellung und Verwendung als Arzneimittel |
US8178583B2 (en) * | 2008-12-19 | 2012-05-15 | Hoffmann-La Roche Inc. | Compounds |
WO2010132554A2 (en) * | 2009-05-12 | 2010-11-18 | Mallinckrodt Inc. | Diaza heterocyclic compounds for phototherapy |
EP2635559A2 (en) * | 2010-11-01 | 2013-09-11 | Neurotune AG | Neurotrypsin inhibitors |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL133621A0 (en) | 1997-06-26 | 2001-04-30 | Lilly Co Eli | Antithrombotic agents |
RU2226529C2 (ru) * | 1997-12-19 | 2004-04-10 | Шеринг Акциенгезельшафт | Производные ортоантраниламида в качестве антикоагулянтов, фармацевтическая композиция и способ лечения |
EP0937711A1 (de) * | 1998-02-18 | 1999-08-25 | Roche Diagnostics GmbH | Neue Thiobenzamide, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel |
US6956988B2 (en) | 1998-08-21 | 2005-10-18 | Avanex Corporation | Optical interleaver |
EP1140903B1 (en) * | 1998-12-23 | 2004-08-04 | Eli Lilly And Company | Aromatic amides |
KR20020047175A (ko) * | 1999-09-17 | 2002-06-21 | 밀레니엄 파머슈티컬스 인코퍼레이티드 | Xa 인자의 억제제 |
AU2001277731A1 (en) | 2000-08-09 | 2002-02-18 | Welfide Corporation | Fused bicyclic amide compounds and medicinal use thereof |
EP1379506A2 (en) * | 2000-11-28 | 2004-01-14 | Eli Lilly And Company | Substituted carboxamides |
US7312235B2 (en) | 2001-03-30 | 2007-12-25 | Millennium Pharmaceuticals, Inc. | Benzamide inhibitors of factor Xa |
DE60221505D1 (de) * | 2001-03-30 | 2007-09-13 | Millennium Pharm Inc | FAKTOR Xa BENZAMIDIN INHIBITOREN |
UA78232C2 (uk) * | 2001-09-21 | 2007-03-15 | Брістол-Майерс Сквібб Компані | Лактамвмісні сполуки та їх похідні як інгібітори фактора ха |
AU2002350217A1 (en) * | 2001-12-04 | 2003-06-17 | Bristol-Myers Squibb Company | Glycinamides as factor xa inhibitors |
PT1489078E (pt) | 2002-03-28 | 2010-02-24 | Mitsubishi Tanabe Pharma Corp | Derivados de benzofurano |
JP2005104838A (ja) * | 2003-01-09 | 2005-04-21 | Tanabe Seiyaku Co Ltd | 縮合フラン化合物 |
-
2004
- 2004-09-03 TW TW093126644A patent/TW200512181A/zh unknown
- 2004-09-24 EP EP04788051A patent/EP1666455A4/en not_active Withdrawn
- 2004-09-24 MX MXPA06003382A patent/MXPA06003382A/es active IP Right Grant
- 2004-09-24 BR BRPI0414460-0A patent/BRPI0414460A/pt not_active IP Right Cessation
- 2004-09-24 CN CNB2004800280312A patent/CN100475777C/zh not_active Expired - Fee Related
- 2004-09-24 WO PCT/JP2004/013892 patent/WO2005030706A1/ja active Application Filing
- 2004-09-24 AU AU2004276128A patent/AU2004276128B2/en not_active Ceased
- 2004-09-24 NZ NZ546160A patent/NZ546160A/en unknown
- 2004-09-24 AR ARP040103460A patent/AR045816A1/es unknown
- 2004-09-24 CA CA002538072A patent/CA2538072C/en not_active Expired - Fee Related
- 2004-09-24 KR KR1020067005726A patent/KR100740820B1/ko not_active IP Right Cessation
- 2004-09-24 RU RU2006114055/04A patent/RU2307829C2/ru not_active IP Right Cessation
- 2004-09-24 JP JP2005514202A patent/JP4571075B2/ja not_active Expired - Fee Related
- 2004-09-24 US US10/571,900 patent/US7375119B2/en not_active Expired - Fee Related
-
2006
- 2006-03-08 IL IL174188A patent/IL174188A0/en unknown
- 2006-03-14 ZA ZA200602131A patent/ZA200602131B/xx unknown
- 2006-04-25 NO NO20061832A patent/NO20061832L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU2004276128A1 (en) | 2005-04-07 |
WO2005030706A1 (ja) | 2005-04-07 |
US7375119B2 (en) | 2008-05-20 |
KR100740820B1 (ko) | 2007-07-19 |
TW200512181A (en) | 2005-04-01 |
BRPI0414460A (pt) | 2006-11-14 |
KR20060095982A (ko) | 2006-09-05 |
MXPA06003382A (es) | 2006-06-08 |
US20060287329A1 (en) | 2006-12-21 |
ZA200602131B (en) | 2007-02-28 |
NZ546160A (en) | 2008-09-26 |
JP4571075B2 (ja) | 2010-10-27 |
CN1860097A (zh) | 2006-11-08 |
AR045816A1 (es) | 2005-11-16 |
RU2006114055A (ru) | 2006-09-10 |
EP1666455A1 (en) | 2006-06-07 |
AU2004276128B2 (en) | 2007-11-29 |
CA2538072C (en) | 2009-08-25 |
IL174188A0 (en) | 2006-08-01 |
NO20061832L (no) | 2006-04-25 |
CA2538072A1 (en) | 2005-04-07 |
JPWO2005030706A1 (ja) | 2006-12-07 |
RU2307829C2 (ru) | 2007-10-10 |
EP1666455A4 (en) | 2009-02-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101762574B1 (ko) | 플라즈미노겐 액티베이터 인히비터-1 저해제 | |
RU2184731C2 (ru) | Амиды аминотиофенкарбоновой кислоты, способ их получения (варианты) и фармацевтическая композиция | |
JP2020537657A (ja) | Nlrp活性に関連する病態を治療するためのスルホンアミド及びその組成物 | |
CN101282948A (zh) | N-(3-氨基-喹喔啉-2-基)-磺酰胺衍生物及其作为磷脂酰肌醇3-激酶抑制剂的用途 | |
JPH06507625A (ja) | アンギオテンシンiiアンタゴニストとしての酸官能基を有する置換ピリミジノン | |
CN100475777C (zh) | 酰胺型甲酰胺衍生物 | |
CN101610996A (zh) | 组蛋白脱乙酰酶抑制剂及其前体药物 | |
WO2012054332A1 (en) | Substituted hydroxamic acids and uses thereof | |
ZA200702688B (en) | Substituted 2H-1,3-benzoxazin-4-(3H)-ones | |
JP2007507551A (ja) | 2,4−ジオキソ−3−キナゾリニルアリールスルホニル尿素 | |
CN102803204A (zh) | 环烷基氨基甲酸酯苯酰胺苯胺hdac抑制剂化合物 | |
CN101679239A (zh) | 组蛋白脱乙酰酶抑制剂 | |
AU2005291297A1 (en) | New histone deacetylases inhibitors | |
CN100439351C (zh) | 苯并呋喃衍生物 | |
US10105363B2 (en) | Histone deacetylase inhibitors and compositions and methods of use thereof | |
CN112920124B (zh) | 一种嘧啶-2,4-二胺类化合物及其制备方法与应用 | |
TW200404791A (en) | NF-kB inhibitors | |
CN101445469B (zh) | 组蛋白脱乙酰基酶抑制剂 | |
JPH1067723A (ja) | 医薬化合物 | |
JP2011201777A (ja) | 光学活性なヘテロシクリデン−n−アリールアセトアミド誘導体 | |
CN100430392C (zh) | 氨甲酰型苯并呋喃衍生物 | |
AU2008317417A1 (en) | Small molecule inhibitors of PARP activity | |
CN115232126B (zh) | 一种β-卡波林-1,2,3-三唑化合物及其制备方法与抗阿尔兹海默病的应用 | |
KR20110021799A (ko) | Ikk-베타 세린-트레오닌 단백질 키나아제의 억제제 | |
JP2006298909A (ja) | 医薬組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: TANABE MITSUBISHI PHARMACEUTICAL CO. Free format text: FORMER OWNER: TANADE SEIYAKU CO., LTD. Effective date: 20080606 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20080606 Address after: Japan Osaka City Plaza Osaka built town 3 chome 2 No. 10 Applicant after: Mitsubishi Tanabe Pharma Corporation Address before: Osaka Japan Applicant before: Tanabe Seiyaku Co., Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090408 Termination date: 20110924 |